Shi X, You X, Zeng W-C, Deng Y-J, Hong H-L, Huang O-X, Wang M-F
Department of Medical Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2462. doi: 10.26355/eurrev_202103_25402.
Since this paper presents several inaccuracies and mistakes, the article "LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p, by X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (24): 10761-10768-DOI: 10.26355/eurrev_201912_19778-PMID: 31858543" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19778.
由于本文存在若干不准确之处和错误，发表于《欧洲医学与药理学评论》2019年；23(24):10761 - 10768 - DOI: 10.26355/eurrev_201912_19778 - PMID: 31858543的文章“X. Shi、X. You、W.-C. Zeng、Y.-J. Deng、H.-L. Hong、O.-X. Huang、M.-F. Wang所著的‘LncRNA PAPAS通过调控miRNA - 188 - 5p加重胃癌进展’”已被撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/19778
